WC
BHVN

Woodstock Corp’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Woodstock Corp’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-5,474
Closed -$798K – 165
2022
Q2 		$798K Hold
5,474
– – 0.11% 101
2022
Q1 		$649K Sell
5,474
-190
-3% -$23.7K 0.08% 116
2021
Q4 		$781K Hold
5,664
– – 0.08% 116
2021
Q3 		$787K Hold
5,664
– – 0.09% 110
2021
Q2 		$550K Buy
+5,664
New +$460K 0.06% 136

Other funds holding BHVN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SFM
Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Woodstock Corp's BHVN Position: Q3 2022 in Review

Woodstock Corp sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q3 2022, closing a stake of 5,474 shares — an estimated $798K sold.

Woodstock Corp first reported a position in BHVN in Q2 2021 and held it in 5 quarters. The position peaked at $798K in Q2 2022. 240 funds tracked by Wall St. Rank hold BHVN as of Q3 2022.

  • Woodstock Corp reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q3 2022 after selling out during the quarter.
  • Woodstock Corp sold 5,474 Biohaven Pharmaceutical Holding Company Ltd. shares in Q3 2022, an estimated $798K.
  • Woodstock Corp first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q2 2021 and held it in 5 quarters.
  • Woodstock Corp's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $798K in Q2 2022.
  • 240 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q3 2022.

Based on Woodstock Corp's 13F filing for Q3 2022, filed 11 Oct 2022.